You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study

Citation Tools

Article menu
Obesity studies
Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wysham CH, Rosenstock J, Vetter ML, et al
Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study
BMJ Open Diabetes Research and Care 2020;8:e000773. doi: 10.1136/bmjdrc-2019-000773